SANeForce Revenue and Competitors
Estimated Revenue & Valuation
- SANeForce's estimated annual revenue is currently $35.9M per year.
- SANeForce's estimated revenue per employee is $159,500
Employee Data
- SANeForce has 225 Employees. 0
SANeForce's People
Name | Title | Email/Phone |
---|---|---|
1 | Business Analyst | Reveal Email/Phone |
2 | Executive - Market Research Analyst & Lead Generation Specialist | Reveal Email/Phone |
SANeForce Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.5M | 17 | -11% | N/A | N/A |
#2 | $191.6M | 957 | 27% | $50M | N/A |
#3 | $104M | 585 | -7% | $127.3M | N/A |
#4 | $36.5M | 229 | -3% | N/A | N/A |
#5 | $4M | 38 | 9% | $71.6M | N/A |
#6 | $96.7M | 544 | -18% | $284M | $1.4B |
#7 | $429.4M | 2145 | -1% | $1.1B | $9.5B |
#8 | $1234M | 6079 | N/A | N/A | N/A |
#9 | $29.5M | 189 | -3% | $119.8M | N/A |
#10 | $0.2M | 6 | 0% | $340K | N/A |
#11 | $1M | 12 | N/A | N/A | N/A |
#12 | $0.7M | 9 | N/A | N/A | N/A |
#13 | $2M | 20 | N/A | N/A | N/A |
#14 | $2M | 27 | -21% | $36M | N/A |
#15 | $2.1M | 21 | N/A | N/A | N/A |
#16 | $4.5M | 0 | N/A | N/A | N/A |
#17 | $11.1M | 79 | 49% | $2.2M | N/A |
#18 | $1.7M | 19 | N/A | N/A | N/A |
#19 | $0.9M | 10 | N/A | N/A | N/A |
#20 | $0.5M | 7 | N/A | N/A | N/A |
What Is SANeForce?
SANeForce: A pioneer software company with 21+ years of service providing pharma SFA, Pharma SFE, CRM software and Sales Force Automation for the industries of Pharmaceutical Industry, Healthcare, FMCG, Consumer Goods and Medical devices, diagnostics Industry. We also deliver HR, Payroll and Attendance software.
keywords:Pharma sales force automation, MR Reporting Software, SFA softwares in pharma, pharma softwareN/A
Total Funding
225
Number of Employees
$35.9M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $25.4M | 225 | 24% | N/A |
#2 | N/A | 226 | -4% | N/A |
#3 | N/A | 228 | 7% | N/A |
#4 | $25.2M | 228 | 20% | N/A |
#5 | $57.9M | 232 | 32% | N/A |